Treatment of permanent tardive dyskinesia with tiapride, a selective D2-receptor blocking agent.
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects; D001549:Benzamides / Q000627:therapeutic use*; D002908:Chronic Disease; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy; D013976:Tiapamil Hydrochloride / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D001549:Benzamides; D013976:Tiapamil Hydrochloride